During the last few decades, emerging research has focused on the role of gut microbiota in metabolic diseases and showed that gut microbiota dysbiosis was intertwined with various disorders, such as glucose intolerance, insulin sensitivity and disturbances of serum lipid profiles (Mithieux, 2018). This evidence concerns the gene INS and Glucose intolerance.